Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

STRUCTURE-FUNCTION OF THE TUMOR SUPPRESSOR BRCA1
Serena L. Clark, Ana M. Rodrı́guez, Russell R. Snyder, et al.
Computational and Structural Biotechnology Journal (2012) Vol. 1, Iss. 1, pp. e201204005-e201204005
Open Access | Times Cited: 192

Showing 1-25 of 192 citing articles:

Phase I Study of Single-Agent AZD1775 (MK-1775), a Wee1 Kinase Inhibitor, in Patients With Refractory Solid Tumors
Khanh Do, Deborah Wilsker, Jiuping Ji, et al.
Journal of Clinical Oncology (2015) Vol. 33, Iss. 30, pp. 3409-3415
Open Access | Times Cited: 298
The breast cancer susceptibility genes (BRCA) in breast and ovarian cancers
Arindam Paul
Frontiers in bioscience (2014) Vol. 19, Iss. 4, pp. 605-605
Open Access | Times Cited: 195
BRCA Genes: The Role in Genome Stability, Cancer Stemness and Therapy Resistance
Ielizaveta Gorodetska, Iryna Kozeretska, Anna Dubrovska
Journal of Cancer (2019) Vol. 10, Iss. 9, pp. 2109-2127
Open Access | Times Cited: 184
Anti-cancer peptide-based therapeutic strategies in solid tumors
Mohsen Karami Fath, Kimiya Babakhaniyan, Maryam Zokaei, et al.
Cellular & Molecular Biology Letters (2022) Vol. 27, Iss. 1
Open Access | Times Cited: 101
BRCA1 and Breast Cancer: Molecular Mechanisms and Therapeutic Strategies
Xiaoyu Fu, Wei Phin Tan, Qibin Song, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 71
Role of BRCA Mutations in the Modulation of Response to Platinum Therapy
Sanghamitra Mylavarapu, Asmita Das, Monideepa Roy
Frontiers in Oncology (2018) Vol. 8
Open Access | Times Cited: 146
Karyopherins in cancer
Tolga Çağatay, Yuh Min Chook
Current Opinion in Cell Biology (2018) Vol. 52, pp. 30-42
Open Access | Times Cited: 102
BRCA1 binds TERRA RNA and suppresses R-Loop-based telomeric DNA damage
Jekaterina Vohhodina, Liana Goehring, Ben Liu, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 75
BRCA1 Deficiency Impairs Mitophagy and Promotes Inflammasome Activation and Mammary Tumor Metastasis
Qiang Chen, Josh Haipeng Lei, Jiaolin Bao, et al.
Advanced Science (2020) Vol. 7, Iss. 6
Open Access | Times Cited: 73
The MAMs Structure and Its Role in Cell Death
Nan Wang, Chong Wang, Hongyang Zhao, et al.
Cells (2021) Vol. 10, Iss. 3, pp. 657-657
Open Access | Times Cited: 67
Homologous recombination proficiency in ovarian and breast cancer patients
Justin F. Creeden, Nisha S. Nanavaty, Katelyn R. Einloth, et al.
BMC Cancer (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 63
Benchmarking of SpCas9 variants enables deeper base editor screens of BRCA1 and BCL2
Annabel K. Sangree, Audrey L Griffith, Zsofia M Szegletes, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 45
Low dose DNA methyltransferase inhibitors potentiate PARP inhibitors in homologous recombination repair deficient tumors
Romain Pacaud, Scott Thomas, Sibapriya Chaudhuri, et al.
Breast Cancer Research (2025) Vol. 27, Iss. 1
Open Access | Times Cited: 1
Breast cancer gene-1 (BRCA1) potentiates maladaptive repair after kidney injury
Amrendra K. Ajay, Akinwande A. Akinfolarin, Cody C. Gifford, et al.
The Journal of Experimental Medicine (2025) Vol. 222, Iss. 6
Closed Access | Times Cited: 1
Combined genetic and splicing analysis of BRCA1 c.[594-2A>C; 641A>G] highlights the relevance of naturally occurring in-frame transcripts for developing disease gene variant classification algorithms
Miguel de la Hoya, Omar Soukarieh, Irene López‐Perolio, et al.
Human Molecular Genetics (2016) Vol. 25, Iss. 11, pp. 2256-2268
Open Access | Times Cited: 79
The Spectrum of Genetic Mutations in Breast Cancer
Asfandyar Sheikh, Syed Ather Hussain, Quratulain Ghori, et al.
Asian Pacific Journal of Cancer Prevention (2015) Vol. 16, Iss. 6, pp. 2177-2185
Open Access | Times Cited: 77
The BRCA1/BARD1-Interacting Protein OLA1 Functions in Centrosome Regulation
Ayako Matsuzawa, Shin‐ichiro Kanno, Masahiro Nakayama, et al.
Molecular Cell (2013) Vol. 53, Iss. 1, pp. 101-114
Open Access | Times Cited: 77
The BRCA1 Tumor Suppressor Binds to Inositol 1,4,5-Trisphosphate Receptors to Stimulate Apoptotic Calcium Release
Serena Clark Hedgepeth, M. Iveth Garcia, Larry E. Wagner, et al.
Journal of Biological Chemistry (2015) Vol. 290, Iss. 11, pp. 7304-7313
Open Access | Times Cited: 71
Beyond DNA: An Integrated and Functional Approach for Classifying Germline Variants in Breast Cancer Genes
Tina Pesaran, Rachid Karam, Robert Huether, et al.
International Journal of Breast Cancer (2016) Vol. 2016, pp. 1-10
Open Access | Times Cited: 64
Molecular Oncology of Breast Cancer
Himanshu Joshi, Michael F. Press
Elsevier eBooks (2017), pp. 282-307.e5
Closed Access | Times Cited: 64
Effect of BRCA mutational status on survival outcome in advanced-stage high-grade serous ovarian cancer
Se Ik Kim, Maria Lee, Hee Seung Kim, et al.
Journal of Ovarian Research (2019) Vol. 12, Iss. 1
Open Access | Times Cited: 64
The aryl hydrocarbon receptor (AhR) as a breast cancer drug target
Jennifer R. Baker, Jennette A. Sakoff, Adam McCluskey
Medicinal Research Reviews (2019) Vol. 40, Iss. 3, pp. 972-1001
Closed Access | Times Cited: 59
BRCA1/2 pathogenic variants in triple-negative versus luminal-like breast cancers: genotype–phenotype correlation in a cohort of 531 patients
Lorena Incorvaia, Daniele Fanale, Marco Bono, et al.
Therapeutic Advances in Medical Oncology (2020) Vol. 12
Open Access | Times Cited: 52
The BRCA1/BARD1 ubiquitin ligase and its substrates
Samuel R. Witus, Mikaela D. Stewart, Rachel E. Klevit
Biochemical Journal (2021) Vol. 478, Iss. 18, pp. 3467-3483
Open Access | Times Cited: 41
Targeting Oncogenic Pathways in the Era of Personalized Oncology: A Systemic Analysis Reveals Highly Mutated Signaling Pathways in Cancer Patients and Potential Therapeutic Targets
Alexandros Karagiannakos, Maria Adamaki, Antonis Tsintarakis, et al.
Cancers (2022) Vol. 14, Iss. 3, pp. 664-664
Open Access | Times Cited: 36
Page 1 - Next Page

Scroll to top